Danielle Janosevic is a Nephrology physician affiliated with Indiana University School of Medicine. OpenAlex indexes 39 publications with 561 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
93%Angiotensin receptor blocker (ARB)23.4%Valsartan54%Losartan Potassium46%Part D<11 patientsCalcium channel blocker22.8%Amlodipine Besylate100%Part D≥13 patients+ 4 more classes in this area
Metabolism & gastrointestinal
7%SGLT2 inhibitor7%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Transcriptomic Diagnosis and Staging of Sepsis-Associated Acute Kidney Injury
Indiana University Indianapolis
FY2026$156,453K08DK139369 - Transcriptomic Diagnosis and Staging of Sepsis-Associated Acute Kidney Injury
Indiana University Indianapolis
FY2025$156,453K08DK139369 - Transcriptomic Diagnosis and Staging of Sepsis-Associated Acute Kidney Injury
Indiana University Indianapolis
FY2024$157,953K08DK139369
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Naga Chalasani, MD
Indiana University School of Medicine
Douglas Zipes, MD
Indiana University School of Medicine
Glen Lehman, MD
Indiana University School of Medicine
Linda Dimeglio, MD
Indiana University School of Medicine
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”